SCHEMBL8974305

SCHEMBL8974305

Cc1ccc(C2=CCC=C2c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.64
CA9 Q16790 10/20 0.64
CA12 O43570 9/20 0.64
CA1 P00915 7/20 0.64
CA5A P35218 2/20 0.64
CA5B Q9Y2D0 2/20 0.64
CA7 P43166 2/20 0.64
CA3 P07451 1/20 0.64
CA6 P23280 1/20 0.64
PTGS2 P35354 9/20 0.54
PTGS1 P23219 3/20 0.54
PTPN7 P35236 1/20 0.47
CA14 Q9ULX7 1/20 0.46
CA4 P22748 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974823 0.84 PTGS2 (0.56) CA2CA9CA12CA1CA5A
SCHEMBL8974679 0.84 PTGS2 (0.47) CA2CA9CA12CA1CA5A
SCHEMBL8974243 0.84 CA2 (0.71) CA2CA9CA12CA1CA5A
SCHEMBL8974890 0.84 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL8974782 0.84 CA2 (0.68) CA2CA9CA12CA1CA5A
SCHEMBL8974091 0.83 PTGS2 (0.56) CA2CA9CA12CA1CA5A
SCHEMBL12692373 0.82 CA12 (0.86) CA2CA9CA12CA1CA5A
SCHEMBL8973815 0.82 CA2 (0.52) CA2CA9CA12CA1CA5A
SCHEMBL8974406 0.82 PTGS2 (0.60) CA2CA9CA12CA1CA7
SCHEMBL8974750 0.82 CA2 (0.64) CA2CA9CA12CA1CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO claimed
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed